# Replimune Group, Inc.: Form 8-K, filed May 18, 2023

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2023-05-18
- Accepted by EDGAR: May 18, 2023, 08:08 ET
- Period: 2023-05-18
- Accession: 0001104659-23-062103
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465923062103/tm2316116d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465923062103/

## Items reported

- Item 2.02: Results of operations
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465923062103/tm2316116d2_8k.htm

Filed May 18, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-062103. Last ingested by Listed: Nov 3, 2026, 20:10 ET. No prices; not investment advice.